Deep Track Capital, LP 13D/13G Filings for Syros Pharmaceuticals, Inc. (SYRS)

Deep Track Capital, LP 13D and 13G filings for Syros Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
08:41 am
Sale		 2024-12-31 13G Syros Pharmaceuticals, Inc.
SYRS		 Deep Track Capital, LP 0
0.000%		 -699,281decrease
(Position Closed)		 Filing
2022-09-19
4:07 pm
Purchase		 2022-09-16 13G Syros Pharmaceuticals, Inc.
SYRS		 Deep Track Capital, LP 699,281
9.990%		 699,281increase
(New Position)		 Filing